MetriTrack develops the BVNTM model G-2000, a computer-assisted breast ultrasound device that utilizes proprietary dynamic mapping technology for precise anatomical referencing and lesion detection. This technology addresses the issue of missed breast cancers in women with dense breast tissue by providing standardized and reproducible ultrasound exams, significantly improving cancer detection rates.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Mammograms often miss breast cancers in women with dense breast tissue, leading to delayed diagnosis and treatment. Traditional breast ultrasound relies heavily on operator skill, resulting in variability and potentially missed small cancers, hindering its widespread adoption as a screening tool.
Solution
MetriTrack's BVN G-2000 (Breast Volume Navigator) is an FDA-cleared, computer-assisted breast ultrasound device designed to improve cancer detection rates in women with dense breast tissue. The system utilizes proprietary dynamic mapping technology with anatomical referencing to standardize and enhance the reproducibility of ultrasound exams. By precisely mapping breast volume and small lesions, the BVN G-2000 aims to provide clinicians with a more reliable and efficient method for detecting potential malignancies. This technology addresses the limitations of traditional handheld ultrasound, offering a more consistent and accurate imaging solution throughout the breast cancer continuum of care, from detection to treatment monitoring. The system is designed to fill the unmet medical need for improved breast cancer screening, potentially saving thousands of lives.
Target Audience
The primary target audience includes radiologists, sonographers, and breast cancer screening centers seeking to improve cancer detection rates in women with dense breast tissue.
Features
- Proprietary dynamic mapping technology for precise anatomical referencing
- Computer-assisted ultrasound for standardized and reproducible exams
- High-resolution imaging to support the precise mapping of breast volume and small lesions
- Designed for use in the entire breast cancer continuum of care, from detection to treatment